Flotetuzumab is a CD123/CD3 Bispecific DART Molecule for AML Research
Acute myeloid leukemia (AML) is a disease along with poor prognosis. AML results from rapid proliferation of immature myeloid cells in the bone marrow. CD123 (IL3RA) is expressed in the…